Urotronic, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2015

Location

Plymouth MN US

Primary Industry

Medical Devices & Equipment

About

Based in Minnesota, US, and founded in 2015, Urotronic, Inc. operates as a medical device company that develops a drug-coated balloon (DCB) called Optilume used for the treatment and prevention of recurrence of urethral stricture. In January 2022, Laborie, Inc., a portfolio company of Investor AB, acquired Urotronic, Inc. from CD Capital, Hillhouse Capital Group, Legend Capital, and Mayo Clinic Ventures. Urotronic provides optilume, which is a urethral drug-coated balloon used as an alternative to endoscopic stricture treatments for male anterior urethral strictures that offers immediate relief.

Current Investors

Mayo Clinic Ventures, Legend Capital, Hillhouse Investment

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors

Website

www.urotronic.com

Verticals

HealthTech

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on, Trade Sale

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Announced	Urotronic, Inc.	06 Sep 2023

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.